EMA Backs Approval of Elahere for Ovarian Cancer ...Middle East

Medscape - News
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Backs Approval of Elahere for Ovarian Cancer )

Apple Storegoogle play

Also on site :



Latest News
before 8 minute